Metastatic sacral chordoma
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2022.195609Keywords:
Chordoma, Sacrum, Tumor metastasis, Case reportsAbstract
Sacral chordomas (SC) are rare primary malignant bone tumors of the vertebral column, with an incidence between 0.000005-0.000027%. The aim of this study is to describe a case of metastatic SC. A 42-year-old man, without comorbid conditions arrived at the referral center, presenting with a sacral lesion. MRI showed a tumor measuring 9.3 cm that was suggestive of myeloma or chordoma. A biopsy with histopathology study was performed, confirming the diagnosis of SC. The patient underwent surgical tumor excision. Six months after surgery, the tumor recurred with metastatic vertebral column implants, soft tissues of the chest wall, liver and pleural space, and the patient became paraplegic. There was no indication of adjuvant radiotherapy and/or chemotherapy. There was also no possibility that imatinib would be approved by the Unified Health System. At about 28 months of monthly clinical follow-up, the patient died. The case presented showed unsuccessful SC surgery, which is associated with a worse prognosis. The patient had systemic tumor dissemination and paraplegia a few months after surgery, dying at 28 months of follow-up.
Downloads
References
Tenny S, Varacallo M. Chordoma. 2022 Feb 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–.
Bakker SH, Jacobs WCH, Pondaag W, Gelderblom H, Nout RA, Dijkstra PDS, et al. Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival. Eur Spine J. 2018;27(12):3043-58.
Pillai S, Govender S. Sacral chordoma : A review of literature. J Orthop. 2018;15(2):679-84.
Yolcu Y, Wahood W, Alvi MA, Kerezoudis P, Okuno SH, Foote RL, et al. Evaluating the Role of Adjuvant Radiotherapy in the Management of Sacral and Vertebral Chordoma: Results from a National Database. World Neurosurg. 2019;127:e1137-44.
Kennamer BT, Gridley DG, Rhines LD, Nair GR, Lettieri SC, Davis KM, et al. Natural History of a Patient with Sacral Chordoma: Case Report and Literature Review. World Neurosurg. 2020;139:132-5.
Whelan JS, Davis LE. Osteosarcoma, Chondrosarcoma, and Chordoma. J Clin Oncol. 2018;36(2):188-93.
Verma S, Vadlamani SP, Shamim SA, Barwad A, Rastogi S, Raj STA. Partial response to erlotinib in a patient with imatinib-refractory sacral chordoma. Clin Sarcoma Res. 2020;10(1):28.
Ferraresi V, Nuzzo C, Zoccali C, Marandino F, Vidiri A, Salducca N, et al. Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients. BMC Cancer. 2010;10:22.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Rafael Everton Assunção Ribeiro da Costa, Ana Raquel Lopes Visgueira, Eugênio de Sá Coutinho Neto, Carlos Eduardo Coelho de Sá

This work is licensed under a Creative Commons Attribution 4.0 International License.